Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 March, 2018 14:27 IST
Sun Pharma to hike stake in Ranbaxy Malaysia to 79.5%
Source: IRIS | 13 Oct, 2017, 09.53AM
Comments  |  Post Comment

Sun Pharmaceutical Industries' one of the wholly owned subsidiaries (collectively Sun Pharma) has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd, Malaysia, by way of purchase of 666,985 shares of face value of MYR 1.00 each (equivalent to 8.3%) of Ranbaxy Malaysia Sdn Bhd.

Ranbaxy Malaysia Sdn Bhd. is a subsidiary of the company, and the total shareholding of Sun Pharmaceutical (Q,N,C,F)* Industries, along with its wholly owned subsidiary is 71.2%, prior to this proposed purchase of shares.

Post completion of this purchase of shares, the total holding of the company along with its wholly owned subsidiary will increase from 71.2% to 79.5% in Ranbaxy Malaysia Sdn Bhd.

Shares of the company declined Rs 1.7, or 0.32%, to trade at Rs 537.70. The total volume of shares traded was 34,613 at the BSE (9.42 a.m., Friday).

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Ashok Leyland bags orders for 2,100 buses from Tamil Nadu - 21-Mar-2018 10:17
Suzlon designs and produces India's longest wind turbine blade of 63 meters - 21-Mar-2018 10:11
Mphasis partners with Plug and Play - 21-Mar-2018 09:55
Force Motors signs JV agreement with MTU Friedrichshafen GmbH - 21-Mar-2018 09:48
TCS partners with Saudi Real Estate Refinance Co - 21-Mar-2018 09:44
GE Power India secures contract worth Rs 3.09 bn - 21-Mar-2018 09:40
Alembic Pharm intimates of USFDA inspection of facility at Panelav - 21-Mar-2018 09:37
Mahindra & Mahindra partners with Standard Chartered - 20-Mar-2018 12:36
BHEL commissions 1st unit of Kishanganga hydro-electric project - 20-Mar-2018 10:12
Suzlon wins two projects of 300 MW and 200 MW each under SECI bid - 20-Mar-2018 10:08
Granules India receives approval for Metformin ER tablets - 20-Mar-2018 10:05
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer